Enhancer ID: | E_01_0635 |
Species: | human |
Position : | chr11:75397365-75399365 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Nothing |
Pubmed ID: | 30428538 |
Enhancer experiment: | Protein purification,Cell culture and transfection,Co-immunoprecipitation assay,Mass Spectrometry,RNA interference and transfection, |
Enhancer experiment description: | The EHEC NleH1 effector inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway by reducing the nuclear translocation of the ribosomal protein S3 (RPS3). NleH1 prevents RPS3 phosphorylation by the I?B kinase-? (IKK?). IKK? is a central kinase in the NF-?B pathway, yet NleH1 only restricts the phosphorylation of a subset of the IKK? substrates. We hypothesized that a protein cofactor might dictate this inhibitory specificity. |
Target gene : | RPS3 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | The EHEC NleH1 effector inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway by reducing the nuclear translocation of the ribosomal protein S3 (RPS3). NleH1 prevents RPS3 phosphorylation by the I?B kinase-? (IKK?). IKK? is a central kinase in the NF-?B pathway, yet NleH1 only restricts the phosphorylation of a subset of the IKK? substrates. We hypothesized that a protein cofactor might dictate this inhibitory specificity. |
TF name : | -- |
TF experiment: | Protein purification,Cell culture and transfection,Co-immunoprecipitation assay,Mass Spectrometry,RNA interference and transfection, |
TF experiment description: | The EHEC NleH1 effector inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway by reducing the nuclear translocation of the ribosomal protein S3 (RPS3). NleH1 prevents RPS3 phosphorylation by the I?B kinase-? (IKK?). IKK? is a central kinase in the NF-?B pathway, yet NleH1 only restricts the phosphorylation of a subset of the IKK? substrates. We hypothesized that a protein cofactor might dictate this inhibitory specificity. |
Enhancer function : | The EHEC NleH1 effector inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway by reducing the nuclear translocation of the ribosomal protein S3 (RPS3). NleH1 prevents RPS3 phosphorylation by the I?B kinase-? (IKK?). IKK? is a central kinase in the NF-?B pathway, yet NleH1 only restricts the phosphorylation of a subset of the IKK? substrates. We hypothesized that a protein cofactor might dictate this inhibitory specificity. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
The EHEC NleH1 effector inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) pathway by reducing the nuclear translocation of the ribosomal protein S3 (RPS3). NleH1 prevents RPS3 phosphorylation by the I?B kinase-? (IKK?). IKK? is a central kinase in the NF-?B pathway, yet NleH1 only restricts the phosphorylation of a subset of the IKK? substrates. We hypothesized that a protein cofactor might dictate this inhibitory specificity. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|